|
ANA Testing
Antinuclear antibody (ANA) test is a sensitive screening test used to detect autoimmune diseases. ANA test is also sometimes called as FANA (fluorescent antinuclear antibody test). The antinuclear antibody test identifies the presence of antinuclear antibodies (ANA) in the blood. Antinuclear antibodies are a group of special antibodies produced by the patient. Antinuclear antibodies (ANAs) are unusual antibodies, detectable in the blood, that have the capability of binding to the nucleus of cells. Auto antibodies, instead of acting against foreign invaders as normal antibodies do, attack the body's own cells, causing various symptoms of auto immune disorders such as organ or tissue inflammation, fatigue, and joint pain.
An antinuclear antibody test is most commonly conducted for the diagnosis of an autoimmune disorder known as systemic lupus erythematosus (SLE). Antinuclear antibodies can provide an indication for doctors to consider the possibility of autoimmune illness.
There are other tests which can be ordered along with the ANA test for the accurate screening of autoimmune disorders. Laboratory tests such as C-reactive protein are also associated with the presence of inflammation. These tests help rule out a diagnosis of other autoimmune disorders. The ANA test is ordered when a patient shows symptoms associated with autoimmune disorders such as low-grade fever, joint pain, fatigue, and/or unexplained rashes that may change over time.
The ANA tests are performed using different assays such as ELISA or indirect immunofluorescence. The results of the test are reported as a titer of immunofluorescence pattern. Different patterns are associated with different auto immune disorders.
An elevated concentration of antinuclear antibodies indicates the results are positive and the increased titer value would be as 1:320, whereas low level titers indicate negative results. Positive ANA tests do not need to be repeated. Changes in the ANA titer do not correlate with disease activity. The presence of ANA in the blood may be due to systemic lupus erythematosus, collagen vascular disease, myositis, rheumatoid arthritis and Sjogren's syndrome.
An ANA report consists of three parts:
• Results: Whether positive or negative • If positive, a titer is determined and reported • If positive, the pattern of fluorescence is reported.
If the patient is detected with SLE, there are two subset tests such as anti-dsDNA and anti-SM that should be ordered to confirm that the condition is SLE. The ANA results are just one factor in diagnosis and must be considered together with the patient's clinical symptoms and other diagnostic tests. The ANA test is complex, but the results and the specific subset test results can give physicians valuable diagnostic information.
However, a positive ANA test result may also be drug-induced. For instance, procainamide and hydralazine are certain medications known to promote the production of ANAs. In this case, the elevated levels of ANA may give false positive results which are not related to any disease.
|